rfhg_29573.1

Basic information about the TSS

---

TSS ID: rfhg_29573.1 Species: human Chr: chr2		Start: 96284369 End: 96284483 Strand: -
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000497539.5:-240 AF085356:-240 GeneID: 23020 HGNC/MGI_ID: HGNC:30859 UniProt_ID: Q9UNV9 Nearer transcript ids and distances:

Gene_name: CIAO1 Gene_symbol: SNRNP200 Gene_synonyms: BRR2 HELIC2 KIAA0788 U5-200KD Gene_source: HGNC:30859

TATA-Box annotation

---

Distance to TSS:	18201
Nearest PromoterID:	NM_004804
Entrez ID:	9391
Nearest Unigene:	Hs.12109
Nearest Refseq:	NM_004804
Nearest Ensembl:	ENSG00000144021
Gene Name:	CIAO1
Gene Alias:	CIA1|WDR39
Gene Type:	protein-coding
CpG%:	0.052632
GC%:	0.530435
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SNRNP200 p2@SNRNP200
Sample		p1@SNRNP200	p2@SNRNP200
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	54.54	36.23
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	58.67	37.02
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	58.64	40.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	51.15	28.07
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	53.77	34.19
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	53.49	37.99
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	66.45	36.60
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	53.53	34.40
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	51.93	34.19
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	59.70	46.37
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	45.68	42.04
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	65.05	41.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.67	8.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	22.85	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	24.81	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	21.88	6.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	18.35	6.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.09	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	5.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	19.56	6.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.97	9.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.92	8.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.48	7.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.50	8.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.51	8.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	16.78	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	17.03	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	23.58	9.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.71	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	20.63	7.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.68	5.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.15	8.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.04	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.59	10.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.75	8.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	20.12	7.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.82	7.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	17.93	9.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	25.93	9.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	23.29	8.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.53	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.79	8.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.40	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.65	6.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	22.89	9.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.96	6.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.39	7.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	21.16	8.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	19.39	8.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.64	6.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	19.06	8.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.90	10.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	167.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.74	7.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.22	8.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	65.44	27.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.91	9.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	15.88	9.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	13.49	7.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.49	11.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	12.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.70	7.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	26.27	15.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.65	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.55	7.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.36	7.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	339.44	177.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	292.21	110.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.63	6.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	4.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.25	5.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.45	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.90	3.97
Adipocyte - breast, donor1	11376-118A8	21.22	9.98
Adipocyte - breast, donor2	11327-117E4	19.25	5.78
Adipocyte - omental, donor1	11473-119C6	20.23	11.07
Adipocyte - omental, donor2	11474-119C7	7.47	5.98
Adipocyte - omental, donor3	11475-119C8	9.71	6.03
Adipocyte - perirenal, donor1	11476-119C9	17.86	5.74
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	19.87	10.84
Adipocyte - subcutaneous, donor3	11408-118E4	23.63	8.86
Adipocyte differentiation, day04, donor1	13019-139D4	44.79	20.14
Adipocyte differentiation, day04, donor2	13022-139D7	29.08	16.99
Adipocyte differentiation, day04, donor3	13025-139E1	36.52	13.94
Adipocyte differentiation, day04, donor4	13028-139E4	42.91	14.11
Adipocyte differentiation, day08, donor1	13020-139D5	42.79	18.02
Adipocyte differentiation, day08, donor2	13023-139D8	37.44	14.20
Adipocyte differentiation, day08, donor3	13026-139E2	30.92	12.80
Adipocyte differentiation, day08, donor4	13029-139E5	23.93	15.02
Adipocyte differentiation, day12, donor1	13021-139D6	27.03	10.40
Adipocyte differentiation, day12, donor2	13024-139D9	22.35	13.31
Adipocyte differentiation, day12, donor3	13027-139E3	22.25	14.73
Adipocyte differentiation, day12, donor4	13030-139E6	23.75	9.44
Alveolar Epithelial Cells, donor1	11510-119G7	19.89	13.92
Alveolar Epithelial Cells, donor2	11590-120G6	14.34	5.74
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	34.72	16.91
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	8.37
Amniotic Epithelial Cells, donor3	11694-123A2	29.38	10.27
Anulus Pulposus Cell, donor1	11248-116E6	27.58	13.16
Anulus Pulposus Cell, donor2	11463-119B5	22.53	10.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	7.64
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.37	4.34
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	12.84
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.63	8.37
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.22	7.92
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.29	6.82
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.82	6.80
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	9.50
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.95	5.65
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	17.42	4.35
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.84	9.06
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.17	6.18
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	7.50
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	17.19	7.18
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	20.31	6.68
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	5.85
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.74	6.47
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	8.41
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	10.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	22.81	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.99	8.25
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	23.53	6.83
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.82	7.41
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.03	6.84
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.55	5.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.83	6.10
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	12.22	6.11
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	4.28
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.21	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.56	11.74
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	21.36	7.63
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	19.36	9.17
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.17	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	16.40	8.20
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.72	6.35
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.63	4.35
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	10.39
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.14	6.44
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	9.27
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	12.68
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.65	7.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.23	7.82
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	8.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.62	7.13
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.90	6.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.28	9.29
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.24	7.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.51	7.17
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.63	6.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	12.21
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.40	4.98
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.92	8.47
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	11.27	5.82
Astrocyte - cerebellum, donor1	11500-119F6	36.97	28.74
Astrocyte - cerebellum, donor2	11580-120F5	28.58	8.22
Astrocyte - cerebellum, donor3	11661-122F5	24.33	9.02
Astrocyte - cerebral cortex, donor1	11235-116D2	48.80	36.95
Astrocyte - cerebral cortex, donor2	11316-117D2	58.40	33.65
Astrocyte - cerebral cortex, donor3	11392-118C6	52.50	24.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	82.00	32.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	87.20	37.33
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	76.70	34.48
Basophils, donor1	12241-129G9	40.28	23.28
Basophils, donor2	12242-129H1	72.52	37.16
Basophils, donor3	12243-129H2	35.43	16.02
Bronchial Epithelial Cell, donor1	11511-119G8	14.23	7.55
Bronchial Epithelial Cell, donor2	11591-120G7	8.69	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.32	13.18
Bronchial Epithelial Cell, donor5	11457-119A8	29.11	14.35
Bronchial Epithelial Cell, donor6	11461-119B3	25.79	9.90
Bronchial Epithelial Cell, donor7	11769-123I5	14.04	7.74
Burkitt's lymphoma cell line:DAUDI	10422-106C8	58.12	65.34
Burkitt's lymphoma cell line:RAJI	10476-106I8	69.64	58.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	43.17	40.61
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	62.05
CD14+ Monocytes, donor1	11224-116B9	49.59	18.03
CD14+ Monocytes, donor2	11305-117B9	43.06	14.11
CD14+ Monocytes, donor3	11381-118B4	43.91	13.83
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	49.25	18.40
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	47.76	28.05
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	55.23	24.66
CD14+ monocytes - mock treated, donor1	11863-125A9	24.28	12.58
CD14+ monocytes - mock treated, donor2	11873-125C1	18.10	12.07
CD14+ monocytes - mock treated, donor3	11883-125D2	23.22	16.35
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.07	9.54
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	19.87	7.45
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.09	10.91
CD14+ monocytes - treated with BCG, donor1	11860-125A6	17.03	5.48
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.02	9.08
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.32	12.40
CD14+ monocytes - treated with Candida, donor1	11868-125B5	15.22	6.79
CD14+ monocytes - treated with Candida, donor2	11878-125C6	19.01	8.98
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	19.93	9.22
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	19.36	12.57
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	20.40	15.41
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	20.36	8.24
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	21.26	14.48
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.08	11.35
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.29	9.68
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	22.16	9.77
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	26.09	15.15
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	16.53	5.70
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	19.02	8.10
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	21.50	12.28
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	17.61	6.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.15	10.04
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	20.26	9.48
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.97	7.78
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	16.23	8.81
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.40	9.28
CD14+CD16+ Monocytes, donor1	11789-124B7	23.76	17.22
CD14+CD16+ Monocytes, donor2	11801-124D1	23.79	11.32
CD14+CD16+ Monocytes, donor3	11912-125G4	19.28	13.43
CD14+CD16- Monocytes, donor1	11788-124B6	35.19	21.49
CD14+CD16- Monocytes, donor2	11799-124C8	30.91	15.02
CD14+CD16- Monocytes, donor3	11910-125G2	55.97	36.79
CD14-CD16+ Monocytes, donor1	11790-124B8	26.03	9.70
CD14-CD16+ Monocytes, donor2	11800-124C9	25.03	11.42
CD14-CD16+ Monocytes, donor3	11911-125G3	24.21	13.69
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	56.90	28.45
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	83.39	28.48
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	80.78	30.03
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	70.36	24.52
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	86.84	34.31
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	87.74	26.67
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	58.04	22.75
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	69.87	30.32
CD19+ B Cells, donor1	11544-120B5	112.60	29.59
CD19+ B Cells, donor2	11624-122B4	86.33	34.82
CD19+ B Cells, donor3	11705-123B4	99.96	36.35
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	125.26	103.44
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	86.29	79.90
CD34+ Progenitors, donor1	11545-120B6	46.19	32.13
CD34+ Progenitors, donor2	11625-122B5	42.14	38.20
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	49.22	46.22
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	48.70	55.69
CD4+ T Cells, donor1	11225-116C1	148.54	59.27
CD4+ T Cells, donor2	11306-117C1	120.64	50.83
CD4+ T Cells, donor3	11382-118B5	103.70	32.33
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	71.72	31.14
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	55.70	23.81
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	56.05	23.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	114.26	35.08
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	120.80	28.09
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	89.00	19.78
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	38.15	29.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	47.96	24.91
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	46.10	25.15
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	68.14	26.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	73.72	26.55
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	95.48	42.68
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	78.00	36.68
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	45.92	20.36
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	50.79	20.38
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	121.55	42.42
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	165.07	53.06
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	129.11	53.80
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	68.05	37.27
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	49.17	23.18
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	56.11	18.07
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	83.42	34.89
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	74.52	21.66
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	126.39	56.66
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	124.21	43.55
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	96.01	33.23
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	94.92	20.94
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	126.00	44.59
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	148.95	47.12
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	117.04	56.98
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	109.94	42.62
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	117.72	44.32
CD8+ T Cells, donor1	11226-116C2	110.66	54.35
CD8+ T Cells, donor2	11307-117C2	102.87	39.04
CD8+ T Cells, donor3	11383-118B6	149.22	39.89
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	37.16	19.50
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.03	20.13
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.00	18.60
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	53.14	18.61
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	35.52	17.04
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.97	19.56
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	38.46	22.60
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	43.96	20.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	38.23	20.87
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	37.73	25.36
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.73	21.50
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	34.90	24.51
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.64	17.95
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	31.88	19.13
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	14.92
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	38.18	18.37
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	36.25	15.25
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	31.82	15.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	49.75	27.25
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	40.29	14.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	37.19	20.20
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	30.21	17.21
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	35.08	19.71
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.23	18.91
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	44.16	16.06
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.96	23.08
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	58.10	19.03
Cardiac Myocyte, donor1	11525-119I4	12.79	12.79
Cardiac Myocyte, donor2	11605-120I3	26.19	16.80
Cardiac Myocyte, donor3	11686-122I3	20.52	10.31
Chondrocyte - de diff, donor1	11261-116G1	26.35	15.60
Chondrocyte - de diff, donor2	11338-117F6	32.69	14.93
Chondrocyte - de diff, donor3	11410-118E6	20.03	6.71
Chondrocyte - re diff, donor2	11339-117F7	64.46	25.07
Chondrocyte - re diff, donor3	11411-118E7	39.23	4.85
Ciliary Epithelial Cells, donor1	11242-116D9	48.66	34.89
Ciliary Epithelial Cells, donor2	11323-117D9	34.20	17.32
Ciliary Epithelial Cells, donor3	11399-118D4	39.47	19.65
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	72.17	36.22
Corneal Epithelial Cells, donor1	11526-119I5	11.64	3.29
Corneal Epithelial Cells, donor2	11606-120I4	9.10	6.83
Corneal Epithelial Cells, donor3	11687-122I4	19.94	10.74
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.01	3.80
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.03	4.73
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	15.98	5.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	73.79	44.76
Dendritic Cells - plasmacytoid, donor2	11309-117C4	87.48	46.35
Dendritic Cells - plasmacytoid, donor3	11385-118B8	76.46	62.43
Endothelial Cells - Aortic, donor0	11207-116A1	44.19	25.02
Endothelial Cells - Aortic, donor1	11263-116G3	24.64	8.80
Endothelial Cells - Aortic, donor2	11340-117F8	38.18	21.49
Endothelial Cells - Aortic, donor3	11412-118E8	29.49	17.30
Endothelial Cells - Artery, donor1	11264-116G4	27.63	14.25
Endothelial Cells - Artery, donor2	11341-117F9	30.59	18.59
Endothelial Cells - Artery, donor3	11413-118E9	44.88	18.41
Endothelial Cells - Lymphatic, donor1	11236-116D3	29.92	15.96
Endothelial Cells - Lymphatic, donor2	11317-117D3	38.64	14.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	32.70	23.40
Endothelial Cells - Microvascular, donor1	11265-116G5	23.47	13.97
Endothelial Cells - Microvascular, donor2	11342-117G1	17.18	17.70
Endothelial Cells - Microvascular, donor3	11414-118F1	25.81	9.78
Endothelial Cells - Thoracic, donor1	11266-116G6	42.01	29.21
Endothelial Cells - Thoracic, donor2	11343-117G2	26.73	15.20
Endothelial Cells - Umbilical vein, donor1	11243-116E1	62.74	40.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	44.32	23.68
Endothelial Cells - Umbilical vein, donor3	11400-118D5	56.79	29.31
Endothelial Cells - Vein, donor1	11267-116G7	17.06	14.79
Endothelial Cells - Vein, donor2	11344-117G3	36.32	21.65
Endothelial Cells - Vein, donor3	11416-118F3	36.58	16.80
Eosinophils, donor1	12244-129H3	15.25	45.74
Eosinophils, donor2	12245-129H4	118.82	61.06
Eosinophils, donor3	12246-129H5	92.74	32.10
Esophageal Epithelial Cells, donor1	11507-119G4	11.73	4.89
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.12	10.67
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.82	2.19
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.56	3.58
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.98	12.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	54.18	20.20
Fibroblast - Aortic Adventitial, donor2	11326-117E3	17.61	6.75
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	51.64	20.29
Fibroblast - Aortic Adventitial, donor3	11401-118D6	31.56	10.96
Fibroblast - Cardiac, donor1	11268-116G8	34.93	12.25
Fibroblast - Cardiac, donor2	11345-117G4	31.83	13.64
Fibroblast - Cardiac, donor3	11417-118F4	18.45	4.42
Fibroblast - Cardiac, donor4	11452-119A3	40.31	21.82
Fibroblast - Cardiac, donor5	11456-119A7	28.05	13.58
Fibroblast - Cardiac, donor6	11460-119B2	32.29	12.43
Fibroblast - Choroid Plexus, donor1	11492-119E7	33.63	23.45
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.28	15.96
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	10.25
Fibroblast - Conjunctival, donor1	11531-120A1	33.21	12.22
Fibroblast - Conjunctival, donor3	11692-122I9	36.46	17.47
Fibroblast - Dermal, donor1	11269-116G9	20.66	5.87
Fibroblast - Dermal, donor2	11346-117G5	36.79	20.28
Fibroblast - Dermal, donor3	11418-118F5	19.95	6.04
Fibroblast - Dermal, donor4	11450-119A1	43.86	16.28
Fibroblast - Dermal, donor5	11454-119A5	41.35	18.84
Fibroblast - Dermal, donor6	11458-119A9	51.98	20.79
Fibroblast - Gingival, donor1	11237-116D4	34.98	13.95
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	37.99	17.29
Fibroblast - Gingival, donor2	11318-117D4	38.35	12.39
Fibroblast - Gingival, donor3	11394-118C8	42.93	10.44
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	35.32	13.51
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	21.32	9.34
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	45.21	25.88
Fibroblast - Gingival, donor6 (control)	11922-125H5	32.32	18.93
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.82	5.65
Fibroblast - Gingival, donor7 (control)	11924-125H7	33.93	17.55
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	44.59	23.86
Fibroblast - Gingival, donor8 (control)	11926-125H9	44.54	22.05
Fibroblast - Gingival, donor9 (control)	11927-125I1	33.75	15.70
Fibroblast - Lung, donor1	11270-116H1	28.55	8.16
Fibroblast - Lung, donor2	11347-117G6	47.75	19.40
Fibroblast - Lung, donor3	11419-118F6	30.81	9.07
Fibroblast - Lymphatic, donor1	11506-119G3	33.32	13.33
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	6.99
Fibroblast - Lymphatic, donor3	11667-122G2	3.92	1.12
Fibroblast - Mammary, donor1	11540-120B1	49.12	23.14
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	49.27	18.43
Fibroblast - Periodontal Ligament, donor2	11319-117D5	58.09	23.66
Fibroblast - Periodontal Ligament, donor3	11395-118C9	47.12	22.95
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	35.11	16.79
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	27.27	9.72
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.18	9.74
Fibroblast - Pulmonary Artery, donor1	11250-116E8	18.90	9.73
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	34.34	11.58
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.72	6.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.56	6.72
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	77.00	33.93
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	23.09	12.08
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	30.55	19.12
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	66.79	27.38
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	37.57	20.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	77.44	23.79
Fibroblast - skin normal, donor1	11553-120C5	23.46	12.47
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	87.62	42.51
Fibroblast - skin normal, donor2	11561-120D4	41.99	16.58
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	92.79	45.64
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.24	17.31
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	37.27	17.10
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	61.09	23.65
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	34.51	18.43
Fibroblast - skin walker warburg, donor1	11554-120C6	34.07	19.40
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.98	4.70
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	38.35	18.30
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.44	12.83
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	28.11	14.83
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	35.01	16.35
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	27.56	37.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	40.84	44.03
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	50.49	60.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	63.15	62.32
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	46.35	39.50
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	48.94	50.92
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	51.02	48.90
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.42	43.05
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	38.03	56.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	60.06	58.79
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	69.45	52.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	40.56	50.23
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	51.17	35.56
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	60.49	42.77
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	40.25	40.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	45.86	28.29
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	56.80	32.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	55.96	26.67
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	41.37	28.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	55.00	42.76
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	44.24	26.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	46.98	33.07
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	66.84	41.73
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	47.79	52.41
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.88	44.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.35	46.79
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	68.38	39.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	48.34	49.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.45	49.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	48.69	33.22
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	71.14	39.55
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	44.19	31.69
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.03	24.47
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	75.52	33.82
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	43.77	37.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	57.09	33.35
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	51.93	26.06
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	47.14	27.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	48.96	33.75
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	52.27	30.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	43.91	25.25
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	42.36	28.90
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	52.22	26.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.94	20.06
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	35.80	20.50
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	38.08	23.45
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	41.75	22.50
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	42.77	20.46
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	36.19	20.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	48.60	36.69
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	37.73	18.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.68	17.96
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	53.63	36.09
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	60.71	103.91
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	54.23	55.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	70.99	98.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	40.68	61.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	29.67	54.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	46.58	71.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	59.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	46.03	62.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	59.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	59.12	69.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	38.08	48.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	47.77	70.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	76.64	63.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	43.63	49.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.63	49.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	49.49	67.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	54.39	55.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	48.91	47.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	31.32	52.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	59.56	56.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	38.18	43.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	33.88	45.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	47.63	55.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	51.55	66.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	42.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	41.13	47.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	38.14	40.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	31.44	26.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	43.15	33.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	56.83	67.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	44.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	58.04	40.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	39.23	35.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	50.87	49.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	59.83	47.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	54.76	39.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	66.10	42.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	48.43	37.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	74.17	45.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	58.49	25.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	35.22	35.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	39.31	39.79
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	30.82	13.70
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.45	6.65
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	24.74	5.62
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.47	7.29
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.28	3.76
Hep-2 cells mock treated, biol_rep1	11898-125E8	42.82	23.56
Hep-2 cells mock treated, biol_rep2	11899-125E9	42.20	25.15
Hep-2 cells mock treated, biol_rep3	11900-125F1	43.45	20.70
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	39.79	21.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	44.49	27.94
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	44.13	20.45
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.24	18.68
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	37.57	20.76
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	33.96	18.90
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.18	10.63
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	13.85	6.92
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	13.22
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.46	10.58
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.80	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.88	11.19
Hepatocyte, donor1	11523-119I2	42.37	29.05
Hepatocyte, donor2	11603-120I1	44.17	19.39
Hepatocyte, donor3	11684-122I1	46.02	11.04
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	65.27	61.35
Intestinal epithelial cells (polarized), donor1	11246-116E4	84.42	49.99
Iris Pigment Epithelial Cells, donor1	11530-119I9	25.93	15.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	73.23	47.76
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	81.25
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	49.84	24.92
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	60.06	22.52
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	28.19
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	32.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	51.98	43.86
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	50.02	23.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	14.52
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	64.85	37.06
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	38.80	26.61
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	31.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	44.09	27.08
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	23.20
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	63.96	24.55
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	80.50	32.20
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	23.90
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	65.19	30.15
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	58.77	42.40
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	72.33	36.97
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	65.55	29.55
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	51.45	18.88
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	58.95	39.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	59.19	38.74
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	58.44	36.84
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	65.72
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	77.16	36.99
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	47.39
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	107.82	36.42
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	79.64	49.77
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	70.37	29.94
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	61.46	36.88
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	78.58	31.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	86.23	29.90
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	64.18	48.69
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	68.08	19.45
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	76.73	27.03
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	15.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	27.88
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	68.27	20.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	63.73	20.78
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	68.39	39.89
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	63.51	26.69
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	51.43	27.23
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	31.04
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	41.24	24.32
Keratinocyte - epidermal, donor1	11272-116H3	22.93	15.83
Keratinocyte - epidermal, donor2	11349-117G8	14.64	10.54
Keratinocyte - epidermal, donor3	11421-118F8	28.59	12.31
Keratinocyte - oral, donor1	11251-116E9	41.43	21.57
Keratocytes, donor1	11527-119I6	37.48	15.47
Keratocytes, donor2	11607-120I5	25.78	11.72
Keratocytes, donor3	11688-122I5	36.75	8.30
Krukenberg tumor cell line:HSKTC	10687-109F3	70.33	13.19
Lens Epithelial Cells, donor1	11529-119I8	19.42	10.79
Lens Epithelial Cells, donor2	11609-120I7	44.06	22.49
Lens Epithelial Cells, donor3	11690-122I7	28.25	19.78
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	29.64	19.80
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	16.19	9.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	27.23	13.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.67	13.44
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	26.16	11.66
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.56	12.18
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.29	11.90
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.18	9.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.69	11.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	14.63	12.66
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	20.94	8.92
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.40	11.66
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.38	13.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.31	9.54
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.94	11.13
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.63	10.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.78	8.11
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.35	17.57
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.75	11.52
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.11	10.25
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	25.89	15.43
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	26.19	14.06
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.23	12.66
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.49	13.62
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.25	14.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.29	10.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.34	10.83
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	8.25
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.24	9.97
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	24.17	14.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.57	8.72
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.91	7.61
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	25.65	12.02
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	24.80	12.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.07	5.44
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.07	8.80
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.09	11.58
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.22	10.04
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.39	9.80
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	15.64	11.02
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	8.73
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	22.10	9.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.05	10.39
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.01	8.82
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	20.72	10.36
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	29.58	19.92
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.29	7.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	23.57	11.04
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	40.79	36.26
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	64.44	29.92
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	36.37	23.01
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	54.58	27.93
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	39.39	10.55
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	39.23	33.62
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	54.62	28.34
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	54.72	16.65
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	48.86	30.31
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	47.70	26.17
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	48.62	27.46
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	60.97	43.36
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	55.97	23.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	46.58	21.17
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	23.32	18.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	57.05	18.85
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	56.30	25.35
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	60.65	28.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	53.99	23.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	66.86	35.88
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	59.14	29.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	54.09	27.47
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	55.64	34.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	56.61	25.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	49.32	22.42
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	48.13	29.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	64.33	40.65
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	47.20	26.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	44.90	32.24
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	62.17	19.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	48.12	23.78
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	48.41	20.51
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	58.29	28.47
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	58.17	22.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	46.31	23.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	65.03	37.53
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	52.12	21.54
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	67.65	25.69
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	58.97	26.32
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	53.09	28.96
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	39.82	27.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	53.62	28.18
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	45.62	30.59
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	58.58	20.87
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	67.41	22.97
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	52.33	31.40
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	42.31	14.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	56.02	19.61
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	44.34	19.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	52.89	24.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	65.11	36.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	36.70	25.41
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	54.81	20.62
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	60.83	30.64
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	56.80	27.54
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	63.68	31.62
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	68.82	35.19
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	49.48	29.69
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	49.30	29.06
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	72.20	36.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	36.90	25.72
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	59.18	24.73
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	59.01	29.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	35.44	24.81
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	48.54	24.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	58.84	25.05
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	48.61	26.13
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	47.73	22.13
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	55.10	21.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	56.81	21.69
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	39.91	18.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	61.48	22.50
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	51.71	20.79
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	42.53	16.09
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	52.45	30.34
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	49.51	13.44
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	52.21	25.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	57.00	21.63
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	56.38	24.27
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	42.17	21.71
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	52.50	26.48
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	30.11	16.06
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	36.89	17.64
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	54.55	27.48
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	34.87	17.44
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	46.23	19.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	50.72	22.79
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	39.88	23.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	51.43	16.42
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	61.03	24.50
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	60.05	34.57
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	49.07	24.53
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	22.86
Macrophage - monocyte derived, donor1	11232-116C8	33.50	16.87
Macrophage - monocyte derived, donor2	11313-117C8	31.56	13.03
Macrophage - monocyte derived, donor3	11389-118C3	35.92	15.21
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.56	12.74
Mallassez-derived cells, donor2	11929-125I3	23.29	16.32
Mallassez-derived cells, donor3	11930-125I4	26.96	18.76
Mammary Epithelial Cell, donor1	11273-116H4	32.09	22.02
Mammary Epithelial Cell, donor2	11350-117G9	30.11	23.45
Mammary Epithelial Cell, donor3	11422-118F9	32.43	16.96
Mast cell - stimulated, donor1	11487-119E2	55.59	48.81
Mast cell, donor1	11563-120D6	43.91	23.25
Mast cell, donor2	11565-120D8	74.59	32.39
Mast cell, donor3	11566-120D9	90.27	31.52
Mast cell, donor4	11567-120E1	76.59	27.48
Mast cell, expanded and stimulated, donor5	11940-126A5	47.35	26.61
Mast cell, expanded and stimulated, donor8	11942-126A7	16.34	23.35
Mast cell, expanded, donor5	11939-126A4	35.22	19.04
Mast cell, expanded, donor8	11941-126A6	35.98	26.44
Melanocyte - dark, donor1	11502-119F8	24.48	13.53
Melanocyte - dark, donor2	11582-120F7	23.88	9.69
Melanocyte - dark, donor3	11663-122F7	37.89	24.99
Melanocyte - light, donor1	11274-116H5	31.73	22.57
Melanocyte - light, donor2	11351-117H1	30.71	22.52
Melanocyte - light, donor3	11423-118G1	26.88	8.67
Melanocyte, donor1 (MC+1)	12641-134G4	35.82	15.20
Melanocyte, donor2 (MC+2)	12739-135I3	28.78	15.33
Melanocyte, donor3 (MC+3)	12837-137B2	30.27	19.02
Meningeal Cells, donor1	11493-119E8	50.99	32.63
Meningeal Cells, donor2	11573-120E7	50.62	26.41
Meningeal Cells, donor3	11654-122E7	26.16	23.88
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	26.80	13.69
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.36	11.37
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	6.54
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.96	7.89
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.75	12.28
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	26.14	9.55
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	24.17	11.87
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	18.26	8.77
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	19.64	9.21
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.58	9.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.50	5.95
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	26.97	10.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.43	7.42
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	27.54	13.45
Mesenchymal stem cells - adipose, donor0	11217-116B2	26.23	11.34
Mesenchymal stem cells - hepatic, donor0	11218-116B3	24.39	7.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	10.89
Mesothelial Cells, donor1	11247-116E5	20.95	7.69
Mesothelial Cells, donor2	12156-128G5	19.52	3.50
Mesothelial Cells, donor3	11402-118D7	21.68	5.20
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	60.76	33.76
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	41.87	21.92
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.69	20.32
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	13.83
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	31.30	12.71
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.08	11.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	18.53
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	34.04	13.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	39.10	17.69
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.25	10.16
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	35.24	15.84
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	25.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	7.96
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.56	12.16
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	10.53
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.16	9.13
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	13.81
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	24.44	5.96
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	10.06
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.06	9.03
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.82	8.79
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	29.86	11.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	19.57	9.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	30.71	10.10
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	22.01	9.78
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.88	9.87
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	26.90	12.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.52	8.76
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	18.76	9.13
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	19.88
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.65	11.69
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.82	9.41
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	10.90
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	7.21
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	27.62	10.41
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	19.20	8.23
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	14.02	6.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	8.15
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.20	9.20
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	7.73
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	9.61
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	6.69
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	24.36	4.87
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	6.63
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.62	8.55
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	23.19	10.07
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	22.73	5.33
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.03	6.73
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	20.78	8.31
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	20.98	9.32
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	6.03
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.04	10.85
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	8.31
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.78	9.11
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	28.47	8.15
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.44	7.77
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	20.59	12.44
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	14.61
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.88	10.41
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.44	13.77
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	21.05	9.61
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.42	10.51
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	26.98	11.94
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	24.27	8.34
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.88	9.38
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.63	9.83
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.34	9.78
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.17	11.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	26.24	13.55
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.97	23.49
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.74	12.51
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	11.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	27.27	10.84
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	8.42
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	30.44	13.64
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	32.60	7.45
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	17.27	15.02
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	20.51	7.72
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.26	11.31
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	11.05
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	20.15	10.99
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	10.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.41	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	32.32	7.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	5.06
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	22.62	12.50
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.90	17.77
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	10.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.69	6.68
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	27.00	17.30
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	27.13
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	106.58	45.94
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.81	6.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.88	8.14
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.05	8.11
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.85	11.35
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	144.75
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.36	7.94
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.35	8.39
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.75	4.31
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.72	5.39
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.45	11.12
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	17.50	5.83
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	3.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	24.94	16.74
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.73	3.58
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.69	11.11
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	6.33
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.33	6.90
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.75	8.35
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.45	11.04
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	141.59	58.15
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	30.97	13.14
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.58	8.47
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	15.67	6.17
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.31	6.44
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	135.42	117.36
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.99	7.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.44	9.47
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.08	5.95
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	5.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.05	7.95
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.45	4.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.77	5.23
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	30.30	9.95
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	7.31
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.36	6.45
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	2.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	25.41	13.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	27.41	11.27
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	107.30	40.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.34	7.32
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.22	3.78
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.11	5.15
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.82	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	40.81	23.81
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	101.16	25.29
Myoblast, donor1	11241-116D8	24.60	12.80
Myoblast, donor2	11322-117D8	33.37	13.23
Myoblast, donor3	11398-118D3	32.96	16.48
NK T cell leukemia cell line:KHYG-1	10777-110G3	64.36	35.90
Natural Killer Cells, donor1	11230-116C6	91.33	37.21
Natural Killer Cells, donor2	11311-117C6	78.71	28.35
Natural Killer Cells, donor3	11387-118C1	87.24	24.85
Neural stem cells, donor1	11275-116H6	63.88	88.19
Neural stem cells, donor2	11352-117H2	96.28	96.28
Neurons, donor1	11494-119E9	52.34	36.41
Neurons, donor2	11574-120E8	53.94	43.59
Neurons, donor3	11655-122E8	39.46	37.82
Neutrophils, donor1	11233-116C9	77.02	30.62
Neutrophils, donor2	11314-117C9	55.08	14.49
Neutrophils, donor3	11390-118C4	100.79	28.71
Nucleus Pulposus Cell, donor1	11252-116F1	37.76	14.49
Nucleus Pulposus Cell, donor2	11409-118E5	23.77	6.51
Nucleus Pulposus Cell, donor3	11462-119B4	18.85	5.82
Olfactory epithelial cells, donor1	11933-125I7	18.03	6.19
Olfactory epithelial cells, donor2	11934-125I8	25.33	9.84
Olfactory epithelial cells, donor3	11935-125I9	22.02	6.70
Olfactory epithelial cells, donor4	11936-126A1	22.30	8.67
Oligodendrocyte - precursors, donor1	11496-119F2	27.08	17.45
Osteoblast - differentiated, donor1	11276-116H7	37.43	12.76
Osteoblast - differentiated, donor2	11353-117H3	17.15	5.72
Osteoblast - differentiated, donor3	11425-118G3	23.59	2.48
Osteoblast, donor1	11277-116H8	44.95	20.91
Osteoblast, donor2	11354-117H4	31.60	23.88
Osteoblast, donor3	11426-118G4	45.68	19.73
Pancreatic stromal cells, donor1	11249-116E7	32.01	12.05
Pericytes, donor1	11491-119E6	12.35	4.01
Pericytes, donor2	11571-120E5	8.15	5.43
Pericytes, donor3	11652-122E5	16.48	2.85
Perineurial Cells, donor1	11499-119F5	30.63	14.58
Perineurial Cells, donor2	11579-120F4	34.78	16.56
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	79.05	39.84
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	54.85	19.10
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	70.92	22.39
Placental Epithelial Cells, donor1	11278-116H9	35.64	10.52
Placental Epithelial Cells, donor2	11355-117H5	19.96	15.52
Placental Epithelial Cells, donor3	11427-118G5	31.02	9.03
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.75	1.58
Preadipocyte - breast, donor1	11467-119B9	15.94	9.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	62.26	26.63
Preadipocyte - breast, donor2	11328-117E5	26.12	8.11
Preadipocyte - omental, donor1	11468-119C1	23.87	11.30
Preadipocyte - omental, donor2	11329-117E6	28.81	12.66
Preadipocyte - omental, donor3	11403-118D8	26.36	7.59
Preadipocyte - perirenal, donor1	11469-119C2	10.83	10.83
Preadipocyte - subcutaneous, donor1	11279-116I1	32.25	16.89
Preadipocyte - subcutaneous, donor2	11356-117H6	32.76	14.34
Preadipocyte - subcutaneous, donor3	11428-118G6	21.97	9.37
Preadipocyte - visceral, donor1	11280-116I2	34.74	23.57
Preadipocyte - visceral, donor2	11357-117H7	26.23	12.42
Preadipocyte - visceral, donor3	11429-118G7	23.93	10.14
Prostate Epithelial Cells (polarized), donor1	11253-116F2	72.56	44.20
Prostate Epithelial Cells, donor2	11331-117E8	13.00	7.45
Prostate Epithelial Cells, donor3	11404-118D9	17.58	5.57
Prostate Stromal Cells, donor1	11254-116F3	31.21	16.40
Prostate Stromal Cells, donor2	11332-117E9	29.40	13.45
Prostate Stromal Cells, donor3	11405-118E1	21.48	9.07
Renal Cortical Epithelial Cells, donor1	11516-119H4	23.72	5.84
Renal Cortical Epithelial Cells, donor2	11596-120H3	27.93	14.56
Renal Epithelial Cells, donor1	11517-119H5	20.29	5.58
Renal Epithelial Cells, donor2	11597-120H4	34.14	7.82
Renal Epithelial Cells, donor3	11678-122H4	29.43	18.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	5.45
Renal Glomerular Endothelial Cells, donor2	11594-120H1	23.45	9.84
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.31	18.87
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.98	9.32
Renal Mesangial Cells, donor1	11518-119H6	27.29	11.66
Renal Mesangial Cells, donor2	11598-120H5	33.23	8.78
Renal Mesangial Cells, donor3	11679-122H5	12.76	3.05
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	35.70	22.01
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.55	8.43
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	30.08	9.26
Retinal Pigment Epithelial Cells, donor0	11215-116A9	31.63	12.70
Retinal Pigment Epithelial Cells, donor1	11528-119I7	37.24	17.05
Retinal Pigment Epithelial Cells, donor2	11608-120I6	18.52	9.26
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.34	15.31
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	59.47	23.92
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	52.71	51.82
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	67.15	69.90
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	111.95	93.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	79.97	66.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	63.26	38.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	77.30	61.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	93.65	64.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	66.90	44.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	79.05	58.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	54.35	37.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	66.11	43.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	79.74	59.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	55.95	32.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	65.25	41.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	79.21	42.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	59.46	35.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	71.64	46.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	69.71	70.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	69.54	42.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	73.49	46.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	70.08	45.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	65.89	36.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	65.87	52.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	85.79	52.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	59.26	39.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	64.14	36.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	87.85	45.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	52.84	31.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	69.25	41.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	78.57	57.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	57.64	35.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.51	49.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	73.53	48.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	61.91	39.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	79.70	45.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	79.05	49.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	46.77	36.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	69.96	47.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	81.26	57.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	54.20	30.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	77.38	49.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	74.63	54.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	48.81	36.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.95	34.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	83.24	59.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	51.14	35.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	65.68	49.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	67.09	42.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	59.48	41.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	98.98	104.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	70.58	46.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	58.17	38.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	60.39	47.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	69.79	50.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	74.86	57.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	76.20	45.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	79.93	46.88
Schwann Cells, donor1	11498-119F4	20.69	7.15
Schwann Cells, donor2	11578-120F3	27.22	3.40
Schwann Cells, donor3	11659-122F3	20.37	10.30
Sebocyte, donor1	11220-116B5	48.75	24.10
Sebocyte, donor2	11301-117B5	22.52	13.79
Sebocyte, donor3	11378-118B1	21.02	7.83
Sertoli Cells, donor1	11255-116F4	19.88	11.60
Sertoli Cells, donor2	11333-117F1	14.12	11.30
Skeletal Muscle Cells, donor1	11281-116I3	33.96	19.09
Skeletal Muscle Cells, donor2	11358-117H8	20.96	9.40
Skeletal Muscle Cells, donor3	11430-118G8	56.85	21.74
Skeletal Muscle Cells, donor4	11451-119A2	31.58	16.18
Skeletal Muscle Cells, donor5	11455-119A6	36.57	18.43
Skeletal Muscle Cells, donor6	11459-119B1	33.70	17.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	45.61	21.42
Skeletal Muscle Satellite Cells, donor2	11321-117D7	38.67	17.69
Skeletal Muscle Satellite Cells, donor3	11397-118D2	45.74	23.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	39.85	24.52
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	38.36	14.48
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	32.06	13.62
Skin - palm, donor1	10286-104F7	75.21	26.86
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.51	3.60
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.17	35.99
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.18	2.99
Small Airway Epithelial Cells, donor1	11256-116F5	16.68	9.73
Small Airway Epithelial Cells, donor2	11334-117F2	19.55	8.30
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	67.03	44.83
Small Airway Epithelial Cells, donor3	11406-118E2	19.79	7.87
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.57	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	43.13	15.12
Smooth Muscle Cells - Aortic, donor0	11210-116A4	26.45	14.70
Smooth Muscle Cells - Aortic, donor1	11283-116I5	21.66	9.28
Smooth Muscle Cells - Aortic, donor2	11360-117I1	29.93	9.84
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	17.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	10.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	27.01	13.71
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.51	8.64
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.51	7.94
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	24.42	12.70
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.63	14.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.08	6.26
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.62	4.07
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.13	7.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	39.65	18.44
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	18.12	5.72
Smooth Muscle Cells - Colonic, donor1	11239-116D6	25.37	14.01
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.70	12.91
Smooth Muscle Cells - Colonic, donor3	11396-118D1	32.01	14.48
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	31.86	15.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	12.93	10.78
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.93	8.07
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12.63	9.90
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	27.72	14.06
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.53	8.96
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.34	6.60
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	5.43
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	49.54	28.08
Smooth Muscle Cells - Prostate, donor1	11257-116F6	32.76	17.04
Smooth Muscle Cells - Prostate, donor2	11335-117F3	22.54	10.02
Smooth Muscle Cells - Prostate, donor3	11465-119B7	16.49	6.34
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.50	14.32
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	16.50	9.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	47.81	11.63
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	41.39	20.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.66	6.06
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.98	7.52
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.19	2.95
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	46.49	23.91
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.56	8.88
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	27.49	13.10
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	31.87	12.24
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.38	11.66
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.91	20.82
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	25.22	8.13
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.09	13.95
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.21	9.28
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.75	6.73
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.74	10.69
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.81	10.31
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.23	11.16
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.37	13.30
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.89	7.38
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.69	13.39
Smooth muscle cells - airway, control, donor1	11966-126D4	15.49	10.67
Smooth muscle cells - airway, control, donor2	11967-126D5	11.58	6.39
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	4.60
Smooth muscle cells - airway, control, donor4	11969-126D7	16.04	7.79
Synoviocyte, donor1	11291-117A4	17.34	10.94
Synoviocyte, donor2	11368-117I9	15.42	5.20
Synoviocyte, donor3	11440-118H9	17.43	5.14
Trabecular Meshwork Cells, donor1	11532-120A2	31.45	15.01
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	11.89
Trabecular Meshwork Cells, donor3	11693-123A1	20.38	5.33
Tracheal Epithelial Cells, donor1	11292-117A5	28.82	15.20
Tracheal Epithelial Cells, donor2	11369-118A1	20.49	5.41
Tracheal Epithelial Cells, donor3	11441-118I1	17.75	8.59
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	57.70	21.65
Urethra, donor2	10319-105A4	55.75	32.37
Urothelial Cells, donor1	11520-119H8	9.30	5.05
Urothelial Cells, donor2	11600-120H7	11.62	3.61
Urothelial Cells, donor3	11681-122H7	9.17	2.52
Urothelial cells, donor0	11216-116B1	30.98	8.69
Whole blood (ribopure), donor090309, donation1	12179-129A1	68.51	30.25
Whole blood (ribopure), donor090309, donation2	12180-129A2	74.34	31.45
Whole blood (ribopure), donor090309, donation3	12181-129A3	43.81	15.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	58.54	27.55
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.09	29.63
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	31.24
Whole blood (ribopure), donor090612, donation2	12183-129A5	52.31	27.53
Whole blood (ribopure), donor090612, donation3	12184-129A6	41.08	12.78
Wilms' tumor cell line:G-401	10809-111A8	57.73	49.10
Wilms' tumor cell line:HFWT	10597-108E3	50.16	16.72
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	47.20	19.83
achilles tendon, donor2	10292-104G4	24.80	12.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	63.99	56.86
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	97.05	96.58
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	118.95	81.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	41.09	47.08
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	61.28	56.50
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	44.62	32.78
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	56.35	36.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	75.79	40.10
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	53.09	47.37
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	71.45	47.37
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	43.61	51.15
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	85.81	54.61
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	54.84	36.95
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	81.04	66.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	57.57	54.36
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	62.28	54.38
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	41.54	24.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	44.81	15.04
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	74.25	48.22
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.09	51.86
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	66.68	41.64
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	71.50	78.40
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	75.05	45.36
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	91.05	91.05
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	36.91	33.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	71.53	58.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	65.61	73.10
adenocarcinoma cell line:IM95m	10796-110I4	57.46	34.15
adipose tissue, adult, pool1	10010-101C1	39.25	17.22
adipose, donor1	10184-103D4	100.86	118.45
adipose, donor2	10185-103D5	35.69	30.41
adipose, donor3	10186-103D6	36.21	37.03
adipose, donor4	10187-103D7	37.27	40.74
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	116.31	54.13
adrenal gland, adult, pool1	10081-102A9	40.01	10.91
adult T-cell leukemia cell line:ATN-1	10421-106C7	84.85	47.76
alveolar cell carcinoma cell line:SW 1573	10708-109H6	51.09	32.87
amniotic membrane cells, donor1	12235-129G3	56.34	11.82
amniotic membrane cells, donor2	12236-129G4	57.48	17.24
amniotic membrane cells, donor3	12237-129G5	71.88	10.31
amygdala - adult, donor10196	10167-103B5	46.25	20.16
amygdala, adult, donor10252	10151-102I7	56.17	25.75
amygdala, newborn, donor10223	10360-105E9	34.86	15.82
anaplastic carcinoma cell line:8305C	10428-106D5	60.61	16.93
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	72.14	29.78
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	85.85	51.78
aorta, adult, pool1	10052-101G7	50.99	12.16
appendix, adult	10189-103D9	90.04	32.99
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	83.92	65.00
artery, adult	10190-103E1	40.76	21.74
astrocytoma cell line:TM-31	10425-106D2	80.26	62.44
b cell line:RPMI1788	10427-106D4	58.44	25.58
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.87	8.60
bile duct carcinoma cell line:HuCCT1	10432-106D9	54.08	21.73
bile duct carcinoma cell line:TFK-1	10496-107C1	74.82	30.46
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	39.71	19.57
bladder, adult, pool1	10011-101C2	56.71	15.32
blood, adult, pool1	10053-101G8	57.58	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	38.54	17.98
bone marrow, adult	10192-103E3	31.72	26.32
brain, adult, donor1	10084-102B3	30.75	17.43
brain, adult, pool1	10012-101C3	37.75	21.38
brain, fetal, pool1	10085-102B4	101.51	45.41
breast carcinoma cell line:MCF7	10482-107A5	88.54	34.03
breast carcinoma cell line:MDA-MB-453	10419-106C5	91.62	49.43
breast, adult, donor1	10080-102A8	31.57	8.21
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	36.71	11.18
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	130.18	61.53
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	73.21	44.89
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	79.40	52.77
carcinoid cell line:NCI-H1770	10703-109H1	39.96	30.09
carcinoid cell line:NCI-H727	10735-110B6	109.93	53.60
carcinoid cell line:SK-PN-DW	10719-109I8	57.68	32.96
carcinosarcoma cell line:JHUCS-1	10642-109A3	109.67	73.47
caudate nucleus - adult, donor10196	10177-103C6	46.05	20.72
caudate nucleus, adult, donor10252	10164-103B2	69.61	20.92
caudate nucleus, adult, donor10258	10379-105H1	39.74	14.52
caudate nucleus, newborn, donor10223	10354-105E3	35.89	18.68
cerebellum - adult, donor10196	10173-103C2	107.79	46.61
cerebellum, adult, donor10252	10166-103B4	111.03	48.89
cerebellum, adult, pool1	10083-102B2	48.64	33.80
cerebellum, newborn, donor10223	10357-105E6	67.25	41.51
cerebral meninges, adult	10188-103D8	49.17	17.15
cerebrospinal fluid, donor2	10294-104G6	21.93	14.62
cervical cancer cell line:D98-AH2	10552-107I3	84.98	61.11
cervical cancer cell line:ME-180	10553-107I4	61.65	38.61
cervix, adult, pool1	10013-101C4	75.49	24.67
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	53.65	19.51
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	10.45
choriocarcinoma cell line:BeWo	10423-106C9	88.36	56.92
choriocarcinoma cell line:SCH	10785-110H2	96.23	42.51
choriocarcinoma cell line:T3M-3	10618-108G6	117.64	38.42
chorionic membrane cells, donor1	12238-129G6	41.31	10.54
chorionic membrane cells, donor2	12239-129G7	37.88	18.39
chorionic membrane cells, donor3	12240-129G8	69.78	17.03
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	43.42	18.18
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	49.95	29.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	50.68	48.78
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	83.46	54.18
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	92.16	58.78
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	78.19	46.83
chronic myelogenous leukemia cell line:K562	10454-106G4	103.06	82.45
chronic myelogenous leukemia cell line:KU812	10409-106B4	64.64	71.15
clear cell carcinoma cell line:JHOC-5	10638-108I8	69.95	26.29
clear cell carcinoma cell line:TEN	10636-108I6	69.92	24.64
colon carcinoma cell line:CACO-2	10513-107D9	73.58	64.98
colon carcinoma cell line:COLO-320	10420-106C6	113.26	74.12
colon, adult, donor1	10082-102B1	55.93	15.47
colon, adult, pool1	10014-101C5	66.04	23.62
colon, fetal, donor1	10070-101I7	46.35	8.03
common myeloid progenitor CMP, donor1	12130-128D6	233.76	137.51
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	70.54	52.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.32	49.66
cord blood derived cell line:COBL-a untreated	10449-106F8	67.97	62.33
corpus callosum, adult, pool1	10042-101F6	78.17	32.84
cruciate ligament, donor2	10295-104G7	43.77	20.26
diaphragm, fetal, donor1	10069-101I6	48.96	16.85
diencephalon, adult	10193-103E4	35.28	15.84
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	76.00	69.57
ductal cell carcinoma cell line:KLM-1	10438-106E6	103.35	63.08
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	47.42	23.83
ductus deferens, adult	10196-103E7	57.81	16.45
duodenum, fetal, donor1, tech_rep1	10071-101I8	44.65	17.28
duodenum, fetal, donor1, tech_rep2	10071-101I8	57.38	32.37
dura mater, adult, donor1	10041-101F5	63.10	22.71
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	59.96	53.08
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	93.28	68.49
embryonic pancreas cell line:1B2C6	10604-108F1	61.66	19.73
embryonic pancreas cell line:1C3D3	10605-108F2	41.17	16.04
embryonic pancreas cell line:1C3IKEI	10606-108F3	54.96	20.07
embryonic pancreas cell line:2C6	10603-108E9	76.18	21.02
endometrial carcinoma cell line:OMC-2	10497-107C2	94.19	45.59
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	50.75	21.20
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	35.06	23.32
epidermoid carcinoma cell line:A431	10426-106D3	50.24	28.90
epidermoid carcinoma cell line:Ca Ski	10431-106D8	71.49	35.97
epididymis, adult	10197-103E8	63.63	16.54
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	52.34	22.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	25.56	17.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	91.21	59.37
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	90.05	52.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	77.41	47.72
esophagus, adult, pool1	10015-101C6	43.96	14.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	62.62	37.32
eye - muscle inferior rectus, donor1	10272-104E2	36.22	16.90
eye - muscle lateral, donor2	10298-104H1	33.67	16.83
eye - muscle medial, donor2	10299-104H2	35.72	8.93
eye - muscle superior, donor2	10297-104G9	41.27	20.64
eye - vitreous humor, donor1	10268-104D7	30.61	14.57
eye, fetal, donor1	10054-101G9	74.24	18.05
fibrosarcoma cell line:HT-1080	10758-110E2	20.64	10.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	79.54	37.04
frontal lobe, adult, pool1	10040-101F4	52.45	33.31
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	112.59	52.54
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	55.68	15.00
gall bladder, adult	10198-103E9	54.56	19.31
gamma delta positive T cells, donor1	11937-126A2	91.27	33.28
gamma delta positive T cells, donor2	11938-126A3	67.98	26.89
gastric adenocarcinoma cell line:MKN1	10614-108G2	60.20	29.15
gastric adenocarcinoma cell line:MKN45	10612-108F9	77.95	22.44
gastric cancer cell line:AZ521	10549-107H9	87.55	69.52
gastric cancer cell line:GSS	10560-108A2	87.86	14.64
gastrointestinal carcinoma cell line:ECC12	10615-108G3	104.86	65.57
giant cell carcinoma cell line:LU65	10487-107B1	43.60	21.57
giant cell carcinoma cell line:Lu99B	10433-106E1	114.21	15.96
glassy cell carcinoma cell line:HOKUG	10688-109F4	64.10	28.18
glioblastoma cell line:A172, tech_rep1	10444-106F3	65.02	40.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	69.38	41.43
glioblastoma cell line:T98G	10485-107A8	54.97	29.47
glioma cell line:GI-1	10413-106B8	50.67	24.02
globus pallidus - adult, donor10196	10175-103C4	48.84	19.68
globus pallidus, adult, donor10252	10161-103A8	63.22	23.43
globus pallidus, adult, donor10258	10367-105F7	26.01	15.06
globus pallidus, newborn, donor10223	10364-105F4	29.84	14.92
granulocyte macrophage progenitor, donor1	12131-128D7	281.42	166.41
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	43.71
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	31.36
granulosa cell tumor cell line:KGN	10624-108H3	28.16	13.76
hIPS +CCl2, biol_rep1	14383-156B9	28.92	44.99
hIPS +CCl2, biol_rep2	14384-156C1	29.72	50.76
hIPS +CCl2, biol_rep3	14385-156C2	33.49	48.95
hIPS, biol_rep1	14380-156B6	14.37	80.49
hIPS, biol_rep2	14381-156B7	27.43	39.78
hIPS, biol_rep3	14382-156B8	35.31	17.66
hairy cell leukemia cell line:Mo	10712-109I1	54.02	26.72
heart - mitral valve, adult	10205-103F7	46.34	9.87
heart - pulmonic valve, adult	10206-103F8	65.63	18.83
heart - tricuspid valve, adult	10207-103F9	52.46	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	44.69	10.00
heart, adult, diseased, donor1	10051-101G6	54.08	8.94
heart, adult, pool1	10016-101C7	55.42	16.10
heart, fetal, pool1	10046-101G1	82.25	35.01
hepatic mesenchymal tumor cell line:LI90	10778-110G4	21.91	7.40
hepatoblastoma cell line:HuH-6	10633-108I3	102.27	60.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	101.55	107.84
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	112.03	118.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	119.55	115.60
hepatoma cell line:Li-7	10484-107A7	63.06	43.15
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	52.96	33.06
hippocampus - adult, donor10196	10169-103B7	35.01	20.82
hippocampus, adult, donor10252	10153-102I9	70.62	28.78
hippocampus, adult, donor10258	10374-105G5	23.40	21.41
hippocampus, newborn, donor10223	10363-105F3	20.44	14.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	53.71	88.50
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	38.29	50.86
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.88	51.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	60.33	55.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	66.36	60.68
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	62.64	69.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	53.72	54.89
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.95	46.10
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.47	36.70
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	58.01	61.33
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	56.73	50.14
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	68.68	68.68
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.50	53.52
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	43.73	49.62
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	40.15	82.04
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	60.14	69.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	50.58	64.54
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	45.98	63.47
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	63.49	44.65
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	64.12	49.56
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	48.86	41.97
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	41.32	45.23
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	41.51	46.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.66	47.23
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	36.03	51.73
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	36.52	44.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	44.91	61.25
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	48.59	56.68
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.34	44.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	47.21	50.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.09	42.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	47.16	41.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	54.38	48.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	42.69	40.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	49.22	48.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	38.31	39.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	34.78	49.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	35.21	61.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	40.98	47.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	53.79	60.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	341.59	387.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	71.48	78.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	64.58	51.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	52.84	42.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	50.53	44.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	36.99	44.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.68	68.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	37.98	31.52
immature langerhans cells, donor1	11904-125F5	65.86	22.04
immature langerhans cells, donor2	11905-125F6	36.44	9.51
insula, adult, pool1	10039-101F3	58.29	39.08
keratoacanthoma cell line:HKA-1	10791-110H8	31.54	18.21
kidney, adult, pool1	10017-101C8	47.56	17.92
kidney, fetal, pool1	10045-101F9	90.33	41.80
large cell lung carcinoma cell line:IA-LM	10509-107D5	74.99	49.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	39.95	18.25
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	39.45	13.95
left atrium, adult, donor1	10079-102A7	27.79	11.44
left ventricle, adult, donor1	10078-102A6	29.33	4.05
leiomyoblastoma cell line:G-402	10721-110A1	79.62	42.68
leiomyoma cell line:10964C	10569-108B2	12.57	6.47
leiomyoma cell line:15242A	10570-108B3	17.39	4.89
leiomyoma cell line:15425	10571-108B4	13.84	7.04
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	11.50
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	65.05	78.04
liposarcoma cell line:KMLS-1	10782-110G8	38.43	14.68
liposarcoma cell line:SW 872	10726-110A6	52.39	26.44
liver, adult, pool1	10018-101C9	48.13	18.64
liver, fetal, pool1	10086-102B5	37.63	15.99
locus coeruleus - adult, donor10196	10182-103D2	34.27	17.79
locus coeruleus, adult, donor10252	10165-103B3	46.69	18.64
locus coeruleus, adult, donor10258	10375-105G6	27.37	9.31
locus coeruleus, newborn, donor10223	10362-105F2	42.90	22.71
lung adenocarcinoma cell line:A549	10499-107C4	67.81	30.31
lung adenocarcinoma cell line:PC-14	10408-106B3	95.83	35.16
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	92.93	33.09
lung, adult, pool1	10019-101D1	41.46	11.81
lung, fetal, donor1	10068-101I5	115.02	48.80
lung, right lower lobe, adult, donor1	10075-102A3	42.16	11.00
lymph node, adult, donor1	10077-102A5	43.55	8.05
lymphangiectasia cell line:DS-1	10727-110A7	41.42	19.07
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	54.64	38.94
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	51.82	35.68
mature adipocyte, donor1	12231-129F8	59.49	16.87
mature adipocyte, donor2	12232-129F9	46.07	23.04
mature adipocyte, donor3	12233-129G1	55.47	22.28
mature adipocyte, donor4	12234-129G2	60.54	19.74
maxillary sinus tumor cell line:HSQ-89	10414-106B9	106.50	62.90
medial frontal gyrus - adult, donor10196	10170-103B8	36.10	20.30
medial frontal gyrus, adult, donor10252	10150-102I6	57.93	24.83
medial frontal gyrus, adult, donor10258	10368-105F8	23.19	15.88
medial frontal gyrus, newborn, donor10223	10352-105E1	42.65	35.82
medial temporal gyrus - adult, donor10196	10183-103D3	40.67	19.58
medial temporal gyrus, adult, donor10252	10156-103A3	60.27	25.68
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	13.48
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	416.25	272.72
medial temporal gyrus, newborn, donor10223	10353-105E2	20.82	14.36
medulla oblongata - adult, donor10196	10174-103C3	36.34	18.17
medulla oblongata, adult, donor10252	10155-103A2	61.61	22.45
medulla oblongata, adult, pool1	10038-101F2	64.98	30.53
medulla oblongata, newborn, donor10223	10361-105F1	38.88	16.32
medulloblastoma cell line:D283 Med	10838-111E1	178.46	112.26
medulloblastoma cell line:ONS-76	10759-110E3	47.44	32.89
melanoma cell line:COLO 679	10514-107E1	39.67	16.39
melanoma cell line:G-361	10465-106H6	52.94	26.33
meningioma cell line:HKBMM	10691-109F7	27.68	8.68
merkel cell carcinoma cell line:MKL-1	10843-111E6	134.82	143.63
merkel cell carcinoma cell line:MS-1	10844-111E7	157.09	118.98
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.06	13.04
mesenchymal precursor cell - adipose, donor2	11748-123G2	25.27	12.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.19	6.63
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.49	9.97
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	22.72	9.24
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	17.35	11.80
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.93	3.95
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.84	10.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	25.20	13.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	26.60	17.42
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	32.86	15.65
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	22.73	10.87
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	34.59	12.45
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.99	8.03
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	20.62	8.37
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.85	10.06
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	24.10	7.86
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.78	6.38
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	46.99	17.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.19	12.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	27.13	8.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.09	9.57
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.75	9.73
mesenchymal stem cell line:Hu5/E18	10568-108B1	37.89	22.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	25.57	8.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.09	11.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.46	14.40
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	25.26	11.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.24	9.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.05	12.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.94	9.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	25.95	8.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	96.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	26.25	13.27
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	23.43	14.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	25.24	12.74
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	40.33	11.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.14	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.02	11.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	35.65	14.18
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	10.94
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	15.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	28.58	10.07
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	33.46	10.18
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	30.39	11.19
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.60	8.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	16.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	14.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	35.58	8.30
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	31.68	10.97
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	54.10
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	32.30	9.50
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.69	7.93
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	8.60
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.67	8.15
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.89	7.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	5.90
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	16.52	9.35
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	13.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	35.11	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	25.24	11.88
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	13.46
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	20.35	10.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	25.79	7.25
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	26.70	6.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	24.71	9.88
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	16.87	8.93
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.58	5.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	8.15
mesodermal tumor cell line:HIRS-BM	10696-109G3	41.01	28.63
mesothelioma cell line:ACC-MESO-1	10493-107B7	84.81	16.06
mesothelioma cell line:ACC-MESO-4	10494-107B8	62.55	37.76
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	17.09
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	32.78	24.25
mesothelioma cell line:Mero-25	10850-111F4	54.47	34.27
mesothelioma cell line:Mero-41	10851-111F5	50.85	19.31
mesothelioma cell line:Mero-48a	10852-111F6	41.85	23.91
mesothelioma cell line:Mero-82	10853-111F7	36.53	22.60
mesothelioma cell line:Mero-83	10854-111F8	43.58	29.11
mesothelioma cell line:Mero-84	10855-111F9	51.31	45.75
mesothelioma cell line:Mero-95	10856-111G1	31.47	21.95
mesothelioma cell line:NCI-H2052	10847-111F1	56.82	28.33
mesothelioma cell line:NCI-H226	10846-111E9	32.76	23.35
mesothelioma cell line:NCI-H2452	10848-111F2	52.27	30.58
mesothelioma cell line:NCI-H28	10845-111E8	83.72	41.99
mesothelioma cell line:No36	10857-111G2	51.54	26.42
mesothelioma cell line:ONE58	10858-111G3	31.97	18.15
migratory langerhans cells, donor1	11901-125F2	64.49	29.36
migratory langerhans cells, donor2	11902-125F3	54.71	22.96
migratory langerhans cells, donor3	11903-125F4	61.20	27.28
mixed mullerian tumor cell line:HTMMT	10689-109F5	41.46	19.59
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.37	9.33
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	72.79	28.79
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	37.49	18.08
myelodysplastic syndrome cell line:SKM-1	10772-110F7	70.22	52.11
myeloma cell line:PCM6	10474-106I6	35.38	16.21
myxofibrosarcoma cell line:MFH-ino	10600-108E6	57.32	24.35
myxofibrosarcoma cell line:NMFH-1	10684-109E9	47.07	24.91
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.49	5.91
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.13	5.37
nasal epithelial cells, donor2	12227-129F4	22.63	9.94
neuroblastoma cell line:CHP-134	10508-107D4	199.69	219.02
neuroblastoma cell line:NB-1	10539-107G8	111.88	99.34
neuroblastoma cell line:NBsusSR	10607-108F4	74.65	71.70
neuroblastoma cell line:NH-12	10555-107I6	140.70	124.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	51.72	23.72
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.10	28.35
neuroectodermal tumor cell line:TASK1	10774-110F9	77.69	35.42
neuroepithelioma cell line:SK-N-MC	10728-110A8	75.02	39.42
neurofibroma cell line:Hs 53.T	10729-110A9	24.22	10.91
neutrophil PMN, donor1	12133-128D9	223.12	14.87
neutrophil PMN, donor2	12137-128E4	92.96	0.00
neutrophil PMN, donor3	12141-128E8	66.29	47.35
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	143.75	156.10
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	78.45	44.03
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	25.33	12.50
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	28.64	10.25
nucleus accumbens, adult, pool1	10037-101F1	60.65	31.22
occipital cortex - adult, donor10196	10172-103C1	51.51	22.66
occipital cortex, adult, donor10252	10163-103B1	75.41	33.28
occipital cortex, newborn, donor10223	10355-105E4	32.75	20.74
occipital lobe, adult, donor1	10076-102A4	56.15	19.42
occipital lobe, fetal, donor1	10073-102A1	76.38	39.48
occipital pole, adult, pool1	10036-101E9	50.93	27.83
olfactory region, adult	10195-103E6	47.38	18.34
optic nerve, donor1	10277-104E7	64.03	26.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.42	21.64
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	64.85	28.30
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	51.47	25.23
oral squamous cell carcinoma cell line:SAS	10544-107H4	62.37	39.04
osteoclastoma cell line:Hs 706.T	10704-109H2	35.86	15.87
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	94.37	42.98
osteosarcoma cell line:HS-Os-1	10558-107I9	89.28	54.29
ovary, adult, pool1	10020-101D2	79.58	29.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	43.63	22.73
pancreas, adult, donor1	10049-101G4	49.85	13.17
pancreatic carcinoma cell line:NOR-P1	10698-109G5	54.51	29.63
papillary adenocarcinoma cell line:8505C	10437-106E5	36.80	15.50
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	61.93	24.84
paracentral gyrus, adult, pool1	10035-101E8	52.72	28.65
parietal cortex, adult, donor10258	10373-105G4	30.83	24.96
parietal lobe - adult, donor10196	10171-103B9	36.68	22.57
parietal lobe, adult, donor10252	10157-103A4	57.01	19.95
parietal lobe, adult, pool1	10034-101E7	53.14	28.82
parietal lobe, fetal, donor1	10072-101I9	94.07	43.64
parietal lobe, newborn, donor10223	10356-105E5	37.39	16.82
parotid gland, adult	10199-103F1	54.88	12.33
penis, adult	10200-103F2	55.86	26.32
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	159.16	40.35
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	47.79	22.00
pineal gland - adult, donor10196	10179-103C8	65.79	32.25
pineal gland, adult, donor10252	10160-103A7	95.94	47.97
pineal gland, adult, donor10258	10377-105G8	47.66	25.08
pituitary gland - adult, donor10196	10180-103C9	77.91	34.40
pituitary gland, adult, donor10252	10162-103A9	126.65	42.74
pituitary gland, adult, donor10258	10378-105G9	83.42	28.09
placenta, adult, pool1	10021-101D3	70.09	33.33
plasma cell leukemia cell line:ARH-77	10840-111E3	57.47	21.45
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	61.17	18.52
pons, adult, pool1	10033-101E6	42.35	26.16
postcentral gyrus, adult, pool1	10032-101E5	56.40	27.98
promyelocytes/myelocytes PMC, donor1	12132-128D8	146.40	60.65
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	33.05
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	23.47
prostate cancer cell line:DU145	10490-107B4	45.01	23.89
prostate cancer cell line:PC-3	10439-106E7	82.95	54.81
prostate, adult, pool1	10022-101D4	54.51	17.78
putamen, adult, donor10196	10176-103C5	61.38	19.36
putamen, adult, donor10252	10152-102I8	43.14	15.69
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	37.16
putamen, adult, donor10258, tech_rep2	10372-105G3	53.64	20.05
putamen, newborn, donor10223	10365-105F5	31.49	28.49
rectal cancer cell line:TT1TKB	10469-106I1	81.75	37.24
rectum, fetal, donor1	10067-101I4	86.24	31.99
renal cell carcinoma cell line:OS-RC-2	10411-106B6	34.98	16.32
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	53.43	7.87
retina, adult, pool1	10030-101E3	83.20	25.84
retinoblastoma cell line:Y79	10475-106I7	106.52	93.53
rhabdomyosarcoma cell line:KYM-1	10787-110H4	46.72	39.34
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	220.46	129.35
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.86	17.43
salivary acinar cells, donor1	11771-123I7	41.44	15.54
salivary acinar cells, donor2	11772-123I8	36.49	16.80
salivary acinar cells, donor3	11773-123I9	39.72	20.52
salivary gland, adult, pool1	10093-102C3	58.34	18.30
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	40.22	20.15
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	42.67	20.92
seminal vesicle, adult	10201-103F3	58.20	19.05
serous adenocarcinoma cell line:JHOS-2	10639-108I9	86.00	32.07
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	32.46	14.59
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	55.19	22.08
serous cystadenocarcinoma cell line:HTOA	10693-109F9	63.94	30.49
signet ring carcinoma cell line:Kato III	10436-106E4	54.05	32.05
signet ring carcinoma cell line:NUGC-4	10483-107A6	66.71	45.16
skeletal muscle - soleus muscle, donor1	10282-104F3	61.00	17.73
skeletal muscle, adult, pool1	10023-101D5	68.00	22.79
skeletal muscle, fetal, donor1	10066-101I3	64.32	26.13
skin, adult, donor1	10074-102A2	67.85	20.36
skin, fetal, donor1	10065-101I2	80.17	25.25
small cell cervical cancer cell line:HCSC-1	10800-110I8	66.37	28.02
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	99.29	72.81
small cell lung carcinoma cell line:DMS 144	10841-111E4	114.88	45.49
small cell lung carcinoma cell line:LK-2	10541-107H1	119.33	87.36
small cell lung carcinoma cell line:NCI-H82	10842-111E5	228.25	52.60
small cell lung carcinoma cell line:WA-hT	10562-108A4	141.43	120.07
small intestine, adult, pool1	10024-101D6	65.10	27.71
small intestine, fetal, donor1	10064-101I1	59.46	20.39
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	44.11	22.05
smooth muscle, adult, pool1	10048-101G3	65.13	16.28
somatostatinoma cell line:QGP-1	10781-110G7	66.74	33.77
spinal cord - adult, donor10196	10181-103D1	40.83	11.01
spinal cord, adult, donor10252	10159-103A6	51.65	24.44
spinal cord, adult, donor10258	10369-105F9	34.59	17.99
spinal cord, fetal, donor1	10056-101H2	74.40	36.59
spinal cord, newborn, donor10223	10359-105E8	45.46	25.26
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	34.95	11.80
spleen, adult, pool1	10025-101D7	54.63	24.45
spleen, fetal, pool1	10044-101F8	66.98	33.37
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	48.24	34.57
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	87.72	38.17
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	40.89	22.71
squamous cell carcinoma cell line:T3M-5	10616-108G4	43.00	14.86
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	62.13	22.85
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	59.73	27.11
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	81.23	40.61
stomach, fetal, donor1	10062-101H8	59.81	25.63
submaxillary gland, adult	10202-103F4	62.66	17.09
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27
substantia nigra, adult, donor10252	10158-103A5	49.23	21.19
substantia nigra, adult, donor10258	10371-105G2	22.76	18.10
substantia nigra, newborn, donor10223	10358-105E7	28.26	13.42
synovial sarcoma cell line:HS-SY-II	10441-106E9	160.03	135.04
temporal lobe, adult, pool1	10031-101E4	57.73	29.58
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	74.08	39.17
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	59.78	63.73
tenocyte, donor1	11763-123H8	20.60	7.68
tenocyte, donor2	11765-123I1	18.69	4.20
tenocyte, donor3	11768-123I4	13.34	6.30
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	104.87	98.07
teratocarcinoma cell line:NCR-G1	10798-110I6	82.01	48.56
teratocarcinoma cell line:PA-1	10807-111A6	53.00	54.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	50.14	41.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	176.98	167.91
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	68.16	46.02
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	90.55	55.70
testis, adult, pool1	10026-101D8	73.98	36.72
testis, adult, pool2	10096-102C6	122.24	64.51
thalamus - adult, donor10196	10168-103B6	39.74	15.46
thalamus, adult, donor10252	10154-103A1	64.08	23.29
thalamus, adult, donor10258, tech_rep1	10370-105G1	43.11	29.25
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.14	5.43
thalamus, newborn, donor10223	10366-105F6	20.71	12.66
throat, adult	10209-103G2	55.93	17.73
throat, fetal, donor1	10061-101H7	77.40	14.93
thymic carcinoma cell line:Ty-82	10803-111A2	67.97	67.17
thymus, adult, pool1	10027-101D9	135.40	66.81
thymus, fetal, pool1	10043-101F7	109.20	50.50
thyroid carcinoma cell line:KHM-5M	10776-110G2	36.70	16.22
thyroid carcinoma cell line:TCO-1	10783-110G9	54.48	14.11
thyroid, adult, pool1	10028-101E1	56.83	10.82
thyroid, fetal, donor1	10060-101H6	61.96	16.35
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	21.56
tongue, adult	10203-103F5	43.26	19.77
tongue, fetal, donor1	10059-101H5	42.56	17.73
tonsil, adult, pool1	10047-101G2	82.75	33.66
trachea, adult, pool1	10029-101E2	44.74	17.75
trachea, fetal, donor1	10058-101H4	56.17	17.70
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	34.01	13.82
transitional-cell carcinoma cell line:5637	10418-106C4	74.97	62.82
transitional-cell carcinoma cell line:JMSU1	10492-107B6	161.70	69.57
tridermal teratoma cell line:HGRT	10694-109G1	68.49	26.64
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	50.28	23.62
umbilical cord, fetal, donor1	10057-101H3	25.04	8.35
uterus, adult, pool1	10100-102D1	78.15	35.66
uterus, fetal, donor1	10055-101H1	66.04	30.20
vagina, adult	10204-103F6	56.22	14.22
vein, adult	10191-103E2	60.72	22.80
xeroderma pigentosum b cell line:XPL 17	10563-108A5	35.78	12.82